🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Dallas

63 posts
Read More

Zayo and NVIDIA target AI network bottleneck with six new long-haul fibre routes

Zayo is working with NVIDIA to expand long-haul fibre capacity across emerging United States AI corridors, linking the semiconductor company’s accelerated-computing ecosystem with Zayo’s largest network construction programme. The infrastructure opportunity is substantial, but undisclosed commercial terms and long construction cycles leave the financial returns dependent on customer commitments, utilisation and disciplined execution.
Artificial intelligence-powered drug discovery takes centre stage as Lantern Pharma establishes Open Medicine AI to commercialize its multi-agent AI co-scientist platform across medicine. Representative image.
Read More

Lantern Pharma just separated its AI platform, but will Open Medicine AI unlock real shareholder value?

Lantern Pharma has established Open Medicine AI as a separate company to commercialize and expand its multi-agent AI co-scientist platform, moving a previously planned separation into an active corporate structure. The decision could give the artificial intelligence business greater strategic focus and access to specialized funding, but ownership, intellectual property, customer revenue and future listing arrangements will determine whether the move creates measurable value for Lantern Pharma shareholders.